FDA Approves Once-Daily HIV Pill Complera
The FDA has approved Gilead's Complera, a combination of the HIV drugs Truvada and Edurant. It's the second complete HIV treatment in a single, once-daily pill. The first, Atripla, was approved in 2006.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.